Literature DB >> 21659797

Cushing's syndrome and adrenal axis suppression in a patient treated with ritonavir and corticosteroid eye drops.

Aoife Molloy, Nicholas J Matheson, Paul A R Meyer, Krishna Chaterjee, Effrossyni Gkrania-Klotsas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659797     DOI: 10.1097/QAD.0b013e328347c09c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

Authors:  Alice Tseng; Michelle Foisy
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  Prescribing for patients taking antiretroviral therapy.

Authors:  Yasmin Hughes; Louise Tomlins; Tim Usherwood
Journal:  Aust Prescr       Date:  2022-06-01

3.  Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.

Authors:  Emilie R Elliot; Aikaterini Theodoraki; Lakshmi R Jain; Neal J Marshall; Marta Boffito; Stephanie E Baldeweg; Laura J Waters
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

4.  Iatrogenic Cushing's Syndrome Following Intra-Articular Triamcinolone Injection in an HIV-Infected Patient on Cobicistat Presenting as a Pulmonary Embolism: Case Report and Literature Review.

Authors:  Marjan Alidoost; Gabriella A Conte; Khushboo Agarwal; Michael P Carson; Danielle Lann; Diane Marchesani
Journal:  Int Med Case Rep J       Date:  2020-06-09

5.  Guidance for the prevention and emergency management of adult patients with adrenal insufficiency.

Authors:  Helen Simpson; Jeremy Tomlinson; John Wass; John Dean; Wiebke Arlt
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

Review 6.  What we have to know about corticosteroids use during Sars-Cov-2 infection.

Authors:  F Ferraù; F Ceccato; S Cannavò; C Scaroni
Journal:  J Endocrinol Invest       Date:  2020-08-28       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.